Technical Analysis for OTIC - Otonomy Inc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 0.00% | |
| Calm After Storm | Range Contraction | 8.26% | |
| Doji - Bearish? | Reversal | 8.26% | |
| Hot IPO Pullback | Bullish Swing Setup | 12.38% | |
| New 52 Week Closing High | Bullish | 3.96% | |
| Calm After Storm | Range Contraction | 3.96% | |
| Inside Day | Range Contraction | 3.96% | |
| New 52 Week Closing High | Bullish | 7.27% | |
| Pocket Pivot | Bullish Swing Setup | 7.27% | |
| Volume Surge | Other | 7.27% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Get a Trading Assistant
Otonomy Inc Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurotrophic factor that is in Phase IIa clinical trials for the repair of cochlear synaptopathy and the treatment of speech-in-noise hearing difficulties. It also develops OTO-510, an otoprotectant for the prevention of cisplatin-induced hearing loss; OTO-825, a gene therapy for the treatment of congenital hearing loss; and OTO-6XX induces hair cell repair and regeneration for the treatment of severe hearing loss. The company has license agreements with University of California and DURECT Corporation; and strategic collaboration with Applied Genetic Technologies Corporation to develop and commercialize gene therapy for congenital hearing loss. Otonomy, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Occupational Safety And Health Biopharmaceutical Organ Systems Gene Therapy Otology Audiology Otorhinolaryngology Perception University Of California
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Date | Title |
|---|
| Indicator | Value |
|---|---|
| 52 Week High | 0.125 |
| 52 Week Low | 0.087 |
| Average Volume | 1,000,834 |
| 200-Day Moving Average | 0.0000 |
| 50-Day Moving Average | 0.0000 |
| 20-Day Moving Average | 0.0000 |
| 10-Day Moving Average | 0.1068 |
| Average True Range | 0.0137 |
| RSI | 68.15 |
| ADX | 0.0 |
| +DI | 23.2777 |
| -DI | 6.3674 |
| Chandelier Exit (Long, 3 ATRs) | 0.0839 |
| Chandelier Exit (Short, 3 ATRs) | 0.1281 |
| Upper Bollinger Bands | 0.0000 |
| Lower Bollinger Band | 0.0000 |
| Percent B (%b) | 0.0 |
| BandWidth | 0.0000 |
| MACD Line | 0.0034 |
| MACD Signal Line | 0.0016 |
| MACD Histogram | 0.0018 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.1405 | ||||
| Resistance 3 (R3) | 0.1397 | 0.1313 | 0.1368 | ||
| Resistance 2 (R2) | 0.1313 | 0.1256 | 0.1318 | 0.1355 | |
| Resistance 1 (R1) | 0.1247 | 0.1221 | 0.1280 | 0.1255 | 0.1342 |
| Pivot Point | 0.1163 | 0.1163 | 0.1180 | 0.1168 | 0.1163 |
| Support 1 (S1) | 0.1097 | 0.1106 | 0.1130 | 0.1105 | 0.1018 |
| Support 2 (S2) | 0.1013 | 0.1071 | 0.1018 | 0.1005 | |
| Support 3 (S3) | 0.0947 | 0.1013 | 0.0993 | ||
| Support 4 (S4) | 0.0955 |
